Name | Description | Patent Applicant | Current Assignee | Inventor | Patent Jurisdiction | Patent Number | Date of Patent | ||
---|---|---|---|---|---|---|---|---|---|
Patent 10238753 was granted and assigned to Valerion Therapeutics on March, 2019 by the United States Patent and Trademark Office. | 10238753 | March 26, 2019 | |||||||
Patent 9610362 was granted and assigned to Valerion Therapeutics on April, 2017 by the United States Patent and Trademark Office. | 9610362 | April 4, 2017 | |||||||
Patent 10017581 was granted and assigned to Valerion Therapeutics on July, 2018 by the United States Patent and Trademark Office. | 10017581 | July 10, 2018 | |||||||
Patent 9114178 was granted and assigned to Valerion Therapeutics on August, 2015 by the United States Patent and Trademark Office. | 9114178 | August 25, 2015 | |||||||
10703824 | July 7, 2020 | ||||||||
Patent 9447394 was granted and assigned to Valerion Therapeutics on September, 2016 by the United States Patent and Trademark Office. | 9447394 | September 20, 2016 | |||||||
10781434 | September 22, 2020 | ||||||||
Patent 10202591 was granted and assigned to Valerion Therapeutics on February, 2019 by the United States Patent and Trademark Office. | 10202591 | February 12, 2019 | |||||||
Patent 10501554 was granted and assigned to Valerion Therapeutics on December, 2019 by the United States Patent and Trademark Office. | 10501554 | December 10, 2019 | |||||||
Patent 10221250 was granted and assigned to Valerion Therapeutics on March, 2019 by the United States Patent and Trademark Office. | 10221250 | March 5, 2019 | |||||||
Patent 8834866 was granted and assigned to Valerion Therapeutics on September, 2014 by the United States Patent and Trademark Office. | 8834866 | September 16, 2014 | |||||||
10781433 | September 22, 2020 | ||||||||
8609615 | December 17, 2013 |